Numinus Wellness Inc. (TSX: NUMI)

Market Cap	14.42M
Revenue (ttm)	23.10M
Net Income (ttm)	-26.99M
Shares Out	316.46M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	844,441
Open	0.0500
Previous Close	0.0450
Day's Range	n/a
52-Week Range	0.0400 - 0.2650
Beta	1.52
Analysts	n/a
Price Target	1.10 (+2,344.44%)
Earnings Date	Jul 15, 2024

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assist...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Payton Nyquvest
• Employees: 200
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: NUMI

Financial Performance

In 2023, NUMI's revenue was 23.18 million, an increase of 256.95% compared to the previous year's 6.49 million. Losses were -30.26 million, -32.59% less than in 2022.